Overview

Location [1]
4q31.21
Protein [2]
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5
Synonyms [1]
hISWI, ISWI, SNF2H, hSNF2H, WCRF135

SMARCA5 is altered in 0.09% of all cancers with astrocytoma, breast invasive ductal carcinoma, clear cell renal cell carcinoma, dermatofibrosarcoma protuberans, and endometrial mixed adenocarcinoma having the greatest prevalence of alterations [3].

SMARCA5 GENIE Cases - Top Diseases

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.